コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 of antibodies to PHF/tau, neurofilament, and beta-amyloid protein.
5 urs in association with elevation of soluble beta amyloid protein (Abeta), but before the appearance
7 the aggregation and deposition of misfolded beta-amyloid protein (Abeta) contribute to this progress
10 ease (AD) is an abnormal accumulation of the beta-amyloid protein (Abeta) in specific brain regions.
13 ow that the Alzheimer's disease-linked human beta-amyloid protein (Abeta) synergistically enhances th
14 ether preoperative cerebrospinal fluid (CSF) beta-amyloid protein (Abeta) to tau ratio, an Alzheimer
15 finding that intracellular expression of the beta-amyloid protein (Abeta) under a neuron-specific pro
16 llular amyloid plaques formed by accumulated beta-amyloid protein (Abeta), a metabolic product of amy
17 characterized by extracellular deposition of beta-amyloid protein (Abeta), intracellular neurofibrill
20 ces were examined by immunocytochemistry for beta-amyloid protein and abnormally phosphorylated tau p
22 Alzheimer-characteristic proteins" including beta-amyloid protein and beta-amyloid precursor protein,
23 siderable evidence exists demonstrating that beta-amyloid protein and its fragments 1-40 and 25-35 (b
24 l histological features are accumulations of beta-amyloid protein and the absence of inflammatory cel
29 's disease (AD), affected neurons accumulate beta amyloid protein, components of which can induce mou
31 precursor protein (beta APP), including its beta-amyloid protein epitope, and increased beta APP-751
33 a new strategy for detection and imaging of beta-amyloid protein in immunohistochemical sections fro
37 reported that a variety of mutations in the beta-amyloid protein precursor gene and the Presenilin-1
38 bs genetically interacts with the Drosophila beta-amyloid protein precursor-like (Appl) protein, the
41 optosis, which then leads to accumulation of beta-amyloid protein, the hallmark feature of Alzheimer
42 nd that nitric oxide produced in response to beta-amyloid protein, thought to be a key mediator of Al
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。